Gray, Ritter & Graham Investigating Avandia Claims

By September 27, 2016Announcements

Gray, Ritter & Graham is currently investing claims involving the use of Avandia and adverse side effects, including heart attacks and strokes. Avandia, a diabetes medication developed and manufactured by pharmaceutical giant GlaxoSmithKline, has been linked to an increased risk of heart attack and stroke. The Food and Drug Administration (FDA) estimates that 83,000 heart attacks were linked to Avandia between 1999 and 2007.

Other studies have shown the drug may cause dangerously low blood sugar levels in patients as well. Liver toxicity and low blood pressure are other problems that have been tied to Avandia.